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The NABC-7 workshop discussions focused on Bioremediation,	Phytosensing,	and	Ecores-
toration; Gene-to-Product	Development; and Regulation,	Consumer	Acceptance	 and	Risk	
Management. For the first two topics, the following aspects were discussed: opportunities 
for innovative applications, obstacles to innovative applications, how public policies could 
overcome the obstacles, and how research and development could be advanced. For the 
third topic, discussants focused on the public’s beliefs and attitudes about agricultural 
biotechnology, actions that industry could undertake to address consumers’ fears and 
concerns. Participants were encouraged by the facilitators to focus on non-food applica-
tions for genetically modified (GM) plant technologies in defining appropriate evaluation 
criteria. The workshop discussants focused largely on impediments to commercializa-
tion and public acceptance of non-food products of biotechnology. The predominant 
observations were that the companies involved in commercialization of new, non-food 
technologies tend to be small, such that the regulatory process is particularly burdensome. 
Broad-ranging recommendations listed below focused on industry, the regulatory agen-
cies, public acceptance and associated policy needs, and the role of public-sector entities 
such as universities and the government:
role of Industry 
• Improve communications between and among scientists in the private and public 
sectors, and with consumers and policymakers. Pro-actively seek partnerships 
with groups who share mutually desired outcomes who would help with funding, 
regulatory approval, commercial development, and market acceptance of geneti-
cally modified products. 
This summary draws upon a verbal report on the workshop discussions delivered at the end of the conference 
by Lori Garkovich (University of Kentucky) who received input from fellow-facilitators Kim Jensen (University 
of tennessee), Bill Park (University of tennessee) and randy Weckman (University of Kentucky).
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• Create more effective messages that fairly and adequately address the costs and 
benefits of biotechnology, emphasizing how GM products can help address criti-
cal public concerns (e.g., improvement of environmental quality).
• Acknowledge public concerns and fears by explaining how the current research, 
development and regulatory processes already guard against potential problems.
regulatory Agencies
• A strong theme of the conference was that regulatory policies should be focused 
on the product rather than the process used to produce it. Therefore, partici-
pants recommended redesigning the regulatory process by basing decisions on 
a broader, different, and more clearly defined set of criteria and developing new 
roles for participants in the process. 
• regulatory decision processes should be transparent and should utilize cost, ben-
efit, and liability analyses that include a cost accounting throughout the life cycle 
of the product to determine the speed and priority of regulatory reviews.
• regulators should clearly define what steps must be completed and what in-
formation is necessary for approval of a genetically engineered product. Small 
companies in particular lack the intellectual infrastructure and financial capital to 
effectively negotiate a regulatory approval process that is still dynamic and often 
lacks clarity with respect to criteria for decision-making.
• As part of redefining the regulatory process, agencies should evaluate current 
definitions and standards for key concepts used in the evaluation and approval 
process and consider their applicability to GM plants with respect to site remedia-
tion, risk assessment, liability and adventitious presence. 
• Dialogues with regulatory agencies and multiple stakeholders should be opened 
in an effort to identify common ground, and encourage regulators to become pro-
active spokespersons in explaining the decisions they render. 
Consumer Acceptance and Public Policies
• For the smoothest path to commercialization to occur, a shift to a “market-
driven” rather than a “science-driven” focus needs to guide the research and 
development process. In particular, because of issues related to GM foods, other 
GM technologies must be developed with a clear understanding of consumer 
acceptance and risk-benefit analyses. These needs are compounded when one 
considers international cultural, social and political environments. 
• A knowledge/information gap exists between scientists who develop technolo-
gies and those who will use them. With respect to the technologies addressed 
at NABC 7, there is a clear opportunity to educate the public about potential 
risks and benefits. With bioremediation in particular, the purchaser is likely to 
be a government agency but perhaps still subject to the same perceptions as the 
general consumer. 
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• It is also recommended that an informed public-policy discussion begin to assure 
that planning and funding for bioremediation activities be placed up-front into 
site-planning for industrial and commercial construction sites. These activities 
should include preference for phytoremediation practices, where possible, at 
federally funded cleanup sites, tax incentives to promote the use of phytoremedia-
tion, and allocation of pollution fines or Superfund monies for this activity.
• Strategies should be employed to build on existing public support for technol-
ogy applications such as the following: animal vaccines and veterinary uses, 
agricultural crop phytosensing to improve the efficiency of crop production, and 
research on plant-made pharmaceuticals (PMPs) directed at “orphan” diseases and 
health needs in developing countries.
• A clear recommendation to encourage continued public acceptance of PMPs is to 
focus such research on crops that cannot cross with other food/feed species, such 
as Nicotiana plants developed by the Kentucky tobacco research and Develop-
ment Center. 
role of Universities, Government and 
Public-Sector Organizations
• Workshop participants recognized the role of public research institutions as a 
driving force in creating knowledge for development of new technologies. It is 
recommended that the reward system of universities be reoriented to encourage 
intellectual efforts directed towards the commercialization pipeline.
• Continued coordination and communication with regard to university-owned 
technologies, as conceptualized by the Public Intellectual Property resource for 
Agriculture (PIPrA), is strongly recommended. The PIPrA initiative recognizes 
the collective strength of public research institutions with respect to the number 
of patents controlled. Most importantly, PIPrA not only serves in clarifying is-
sues related to freedom to operate, but also promises to inform and streamline the 
regulatory approval process. 
• Creation of a repository of novel GM organisms was recommended to ensure 
their preservation for possible future use. Development of many products is in 
abeyance due to the current climate of regulatory requirements and consumer 
acceptance, which collectively result in less venture capital investment. 
• The workshop participants advocated study by a newly commissioned National 
research Council committee to examine scientific, regulatory and liability issues 
related to non-food, non-energy uses of GM plants. The charge should include 
evaluating the roles of phytoremediation and PMPs in enhancing environmental 
quality and human health and to make recommendations on regulatory aspects.
• Increase funding to regulatory agencies sufficient to address the greater challenge 
posed by biotechnology research and its commercial products.
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• Universities also need to expand the scope of work of their Offices of technology 
transfer to include seeking potential partners for GMO research at the beginning 
so that commercialization issues (such as market applications) can be incorpo-
rated into the research and development process. 
• Universities should promote science literacy by developing K– science educa-
tion modules to introduce students to biotechnology and working with state 
curriculum committees to include biotech issues in science curricula.
• A recurring theme of the conference was that public-sector entities like NABC, 
universities, and government agencies should strive to improve communications 
between/among scientists, industry, public and policymakers, with particular 
emphasis on risks and benefits of new technologies. It is considered that the 
extension services of land-grant universities could be important forces in reinvigo-
rated communications efforts. These efforts should acknowledge public concerns 
and fears by explaining how the current research, development and regulatory 
processes already guard against potential problems.
